水化治疗对糖尿病肾病患者对比剂肾病的预防作用

谭明红; 陈兵

您当前的位置：

首页 >

文章列表页 >

水化治疗对糖尿病肾病患者对比剂肾病的预防作用

论著 | 更新时间：2025-01-15

- 水化治疗对糖尿病肾病患者对比剂肾病的预防作用
- Preventive effect of hydration therapy on contrast-induced nephropathy in diabetic nephropathy patients
- 陆军军医大学学报 2011年33卷第20期页码：2184-2186
- 作者机构：
  
  第三军医大学西南医院内分泌科
- 作者简介：
- 基金信息：
- DOI：
  中图分类号： R692;R457.2;R587.1
- 纸质出版日期：2011，
  
  网络出版日期：2011-10-30，
- 稿件说明：
移动端阅览
谭明红, 陈兵. 水化治疗对糖尿病肾病患者对比剂肾病的预防作用[J]. 陆军军医大学学报, 2011,33(20):2184-2186.

TAN MINGHONG, CHEN BING. Preventive effect of hydration therapy on contrast-induced nephropathy in diabetic nephropathy patients. [J]. Journal of army medical university, 2011, 33(20): 2184-2186.
谭明红, 陈兵. 水化治疗对糖尿病肾病患者对比剂肾病的预防作用[J]. 陆军军医大学学报, 2011,33(20):2184-2186. DOI：

TAN MINGHONG, CHEN BING. Preventive effect of hydration therapy on contrast-induced nephropathy in diabetic nephropathy patients. [J]. Journal of army medical university, 2011, 33(20): 2184-2186. DOI：

摘要

目的观察水化治疗对使用非离子等渗对比剂的糖尿病肾病患者对比剂肾病的预防作用。方法 2007年1月至2010年12月本科收治的糖尿病肾病患者80例，其中男性30例，女性50例，年龄（64.4±9.3）岁，分为2组：①水化治疗组（

=39），在使用非离子等渗对比剂（碘克沙醇 320 mg/ml）进行多检测器行列螺旋式计算机体层摄影（multidetector-row helical computerized tomography，MDCT）检查前后12 h内予0.9%盐水以1 ml/（kg·h）的速度滴注进行水化，静脉补液量根据患者的体质量及患者心功能进行调整，要求患者24 h尿量达到2 L以上以达到充分水化。②常规治疗组（

=41），按患者正常治疗流程，不额外增加患者的饮水量及静脉液体输入量。记录和分析2组患者在检查前后48、72、168 h的血清肌酐浓度（SCr）变化情况。结果水化治疗组的血肌酐基础值为（160.9±62.7）μmol/L，给予非离子对比剂后48、72、168 h的血肌酐值分别为（145.8±78.7）、（143.1±47.6）、（153.8±59.8）μmol/L 。水化治疗组的4次血肌酐值差异无统计学意义（

>0.05）。常规治疗组的血肌酐基础值为（180.3±91.4）μmol/L，给予非离子对比剂后48、72、168 h的血肌酐值分别为（185.5±71.3）、（188.7±104.3）、（188.3±90.6）μmol/L，常规治疗组给予对比剂前后的4次血肌酐值差异也无统计学意义（

>0.05）。但水化治疗组对比剂肾病发生率低于常规治疗组（

0.05）。结论水化治疗可减少对比剂肾病的发生。

Abstract

Objective To determine the prevention effect of hydration therapy on contrast-induced nephropathy(CIN) in diabetic nephropathy patients using non-ionic iso-osmolar contrast medium. Methods A total of 80 diabetic nephropathy patients (

30 males and 50 females

mean age 64.4±9.3) who were admitted to our department from January 2007 to December 2010 were enrolled in this study. They were randomly divided into 2 groups

saline hydration group (

=39) and conventional therapy group. The patients of the former group received intravenous injection of 0.9% NaCl solution at a rate of 1 ml/(kg·h) for 12 h before and after contrast media administration for multidetector-row helical computerized tomography (MDCT). The quantity of fluid was adjusted according to their body weight and cardiac function. Their urine volume within 24 h were required to be at least 2 liters to guarantee sufficient hydration. For the patients from the conventional therapy group

they received no additional water and fluid therapy. Patients of both group received an injection of non-ionic iso-osmolar contrast medium (iodixanol 320 mg/ml) before MDCT. Serum level of creatinine (SCr)were recorded and analyzed just before and 48

and 168 h after the administration. Results The baseline of SCr in saline hydration group was 160.9±62.7 μmol/L

and the level became 145.8±78.7

143.1±47.6 and 153.8±59.8 μmol/L

respectively in 48

72 and 168 h after the administration of non-ionic iso-osmolar contrast medium. There was no significant difference among them (

>0.05). The baseline of SCr in conventional therapy group was 180.3±91.4 μmol/L

and then the levels were 145.8±78.7

143.1±47.6 and 153.8±59.8 μmol/L

respectively in 48

72 and 168 h after the administration. The SCr showed no difference before and after administration in the conventional therapy group

either (

>0.05). However

the incidence of CIN was lower in the hydration group than that in conventional therapy group (

0.05). Conclusion The incidence of CIN is lowered when saline hydration is used.

关键词

糖尿病肾病对比剂肾病非离子等渗对比剂水化治疗

Keywords

diabetic nephropathiescontrast-induced nephropathynon-ionic iso-osmolar contrast mediumsaline hydration therapy

references

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

口服水化预防门诊高危人群对比剂肾病临床分析